Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
184
datasets available to search
ShareScore release 0.9.0
Dataset results
184 results for “Hyperparathyroidism”
Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Di
ClinicalTrials.gov study NCT01265992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT00990704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
ClinicalTrials.gov study NCT02102204. IPD Sharing: Not stated. Countries: 24. Publications: 0.
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
ClinicalTrials.gov study NCT03280264. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
ClinicalTrials.gov study NCT00664430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
ClinicalTrials.gov study NCT00975000. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT00307840. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism
ClinicalTrials.gov study NCT00004843. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism
ClinicalTrials.gov study NCT00936988. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT04064827. IPD Sharing: YES. Countries: 2. Publications: 0.
Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine
ClinicalTrials.gov study NCT02888639. IPD Sharing: NO. Countries: 0. Publications: 1.
Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
ClinicalTrials.gov study NCT01704079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT00117052. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)
ClinicalTrials.gov study NCT00828347. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT01341782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)
ClinicalTrials.gov study NCT00936650. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism
ClinicalTrials.gov study NCT01134562. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
ClinicalTrials.gov study NCT01224782. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Vitamin D Repletion in Primary Hyperparathyroidism
ClinicalTrials.gov study NCT01306656. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery
ClinicalTrials.gov study NCT01138475. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.